CNS Flashcards
Focal seizure treatment
First line - lamotrigine/ levetiracetam
Second line - Carbamazepi, oxcarbazepine, zonisamide
Generalised tonic clonic treatment
First line - Sodium valproate
Second line - lamotrigine/ levetiracetam
Absence seizure treatment’s
First line - Ethosuximide
Second line - sodium valproate
Absence seizure with other
First line - sodium valproate
Second line - lamotrigine/ levetiracetam
Myoclonic treatment
Sodium valproate
Second line- levetiracetam
Atonic seizure treatment
First line - sodium valproate
Second line - lamotrigine
Tonic seizure treatment
First line - sodium valproate
Second line - lamotrigine
Treatment of status epilepticus
- IV lorazepam (if resuss available/ buccaneers midazolam/ rectal diazepam
- Second dose if seizure not stopped within 5-10 mins
- Levetiracetam/ phenytoin/ sodium valproate
- Try another of the 3
- Phenobarbital / general anaesthetic if no response still
Category 1 Antiepileptics
Carbamazepine, phenytoin, phenobarbital, primidone
Maintain brands
Category 2 Antiepileptic drugs
Clobazam, clonazepam, lamotrigine, oxcarbazepine, perampanel, topiramate, rufinamide, valproate, zonisamide
Use clinical judgement for brands
Category 3 Antiepileptic drugs
Brivaracetam, ethosuximide, gabapentin, lacosamide, levetiracetam, pregabalin, tiagabine, vigabatrin
Carbamazepine, phenytoin, sodium valproate drug interactions
- Hepatotoxicity - Amiodarone, itraconazole, macrolides, alcohol
- CYP enzyme - INDUCERS; Phenytoin, phenobarbital, carbamazepine/ INHIBITORS sodium valproate
- Lower seizure threshold - tramadol, theophylline, quinolones
CARBAMAZEPINE & hyponatraemic - ssri, diuretics
PHENYTOIN &Antifolates - methotrexate, trimethoprim
Carbamazepine, phenytoin, valproate side effects
Depression, suicide, hepatotoxic, hypersensitivity, blood dyscrasia, vit D deficiency (bone pain)
CARBAMAZEPINE: oedema, hyponatraemia
Phenytoin: coarsen appearance, face hair
Sodium valproate: teratogenic ! Pancreatitis
Antiepileptics likely to cause hypersensitivity
Category 1 & lamotrigine
Antiepileptics likely to cause skin rash
Lamotrigine ( Steven Johnson’s syndrome )
Antiepileptics likely to cause blood dyscrasia (C.VET.PLZ)
Carbamazepine, valproate , ethosuximide, topiramate, phenytoin, lamotrigine, zonisamide
Antiepileptics likely to cause eye disorders
Topiramate ( secondary glaucoma)
Vigabatrin (reduced field)
Antiepileptics likely to cause encephalopathy
Vigabatrin
Antiepileptics likely to cause respiratory depression
Gabapentin, pregabalin
Therapeutic range of carbamazepine
4-12mg/L
Signs of carbamazepine toxicity (HANDBAG)
Hyponatraemia, Ataxia, nystagmus, drowsiness, blurred vision, GI disturbance
Phenytoin therapeutic range
10-12mg/L
Signs of phenytoin toxicity (SNACHD)
Slurred speech,Nystagmus, ataxia, confusion, hyperglycaemia, double vision
Driving after unprovoked/ single seizure
Notify DVLA, leave 6 months
Driving after established epilepsy
1yr/ pattern of seizures established over 1 yr with no impact on consciousness
Driving after Antiepileptics med change/ withdrawal
At least 6 months after dose change
If seizure occurs; license revoked for 1yr, reinstate after y months if treatment resumed and no further seizures
Antiepileptics high presence in breast milk (PELZ)
Primidone, ethosuximide, lamotrigine, zonisamide
Antiepileptics with risk of drowsiness in breast milk (PPB)
Phenobarbital, primidone, benzodiazepines
Antiepileptics with breast milk withdrawal effects if sudden stop (PPBL)
Phenobarbital, primidone, benzodiazepines, lamotrigine
Bipolar acute treatment
Benzodiazepines/ Antipsychotics ( quetiapine, olanzapine, risperidone)
Add ons - lithium/ sodium valproate
Managing mania/ hypomania in bipolar
- Stop antidepressant & start antipsychotic (olanzapine, risperidone, quetiapine)
- Try alternative antipsychotic
- Lithium
Managing depression in bipolar
- Psycho intervention
Mod - severe ; Fluoxetine & olanzapine, quetiapine, lamotrigine
Managing bipolar disorder long term
- Lithium
- Antipsychotic
Lithium therapeutic range
0.4-1mmol/L (0.8-1mmol/L acute)
Frequency of lithium monitoring
12 hours after dose, weekly till stable for first year then 6 monthly
Signs of lithium toxicity (REVNG)
Renal impairment/incontinence, extra pyramid tremors, visual disturbance (blurred), nervous system (confusion/restless), gi disorders (diarrhoea, vomit)
SICK & TREMOR
Lithium side effects
Thyroid disorders, nephrotoxicity, rhabdomyolysis, Qt prolongation, benign intracranial hypotension
Lithium interactions
Hyponatraemia (increase risk of toxicity ) - diuretics
Salt imbalance
Serotonin syndrome - ssri, tca
Extrapyramidal side effects - metoclopramide! Haloperidol
Qt prolongation - tramadol, theophylline
Re ally cleared drugs (increase toxicity)
Reduce seizure threshold
Hypokalaemia
Treatment of mild-mod dementia
Acetycholinesterase inhibitors; donepezil, rivastigmine, galantamine
Treatment of mod- severe dementia
Memantine
Treatment of aggravation in dementia
Benzodiazepines/ antipsychotic
Side effects of increased acetylcholine (DUMBBELS)
Diarrhoea, urinary incontinence, muscle weakness, bradycardia, bronchospasm, emesis, lacrimation, salivating
Treatment for Parkinson’s if motor symptoms decrease QOL
Levodopa + carbidopa/benserazide
Treatment for Parkinson’s if motor symptoms don’t effect QOL
Levodopa, non-ergot DA receptor, MAO-B Inhibitors
Action of carbidopa or benserazide
Prevent breakdown of levodopa before crossing BBB
Side effects of levodopa
Impulse disorders, sudden onset of sleep (treat with modalafil), red urine
Non- ergot derived DA receptor
Pramipexole, ropinirole, rotigotine
Non ergot da receptor side effects
Impulse disorders, sudden onset of sleep, hypotension
MAO-B Inhibitors
, selegiline, rasagiline
MAO-I interactions
Phenylephrine (hypertensive crisis)
Tyramine rich foods
Parkinson’s progression despite optimum levodopa
ADD non-ergot da receptor, mao b inhibitor, COMT inhibitors
COMT inhibitor side effects
Entacapone - red urine
Tolcapone - hepatotoxic
Increase sympathomimetic side effects- increased cvd
Nocturnal akinesia treatment
- Levodopa/ da receptor
- Rotigotine
Parkinson’s symptoms not fully controlled by adjunct non ergot
Ergot derived - bromocriptine, cabergoline
First gen (phenothiazines) antipsychotic GROUP 1
PROMAZINES; MOST sedation, MODERATE antimuscarinic, extra pyramid
Chlorpromazine, levopromazine, promazine
First gen group 2 phenothiazine antipsychotic (cyazine)
Pericyazine
MODERATE sedation LEAST extra pyramid
First gen group 3 phenothiazines antipsychotic (azines)
MOST extra pyramid, MODERATE sedation
Fluphenazine, prochlorperazine, trifluperazine
First gen butyrophenone antipsychotic (PERIDOLS)
Benperidol, haloperidol
SIMILAR TO GROUP 3- HIGH extra pyramid, MODERATE sedation
First gen thioxanthenes antipsychotic (PENTIXOL)
Flupentixol, zuclopenthiol
Moderate sedation - antimuscarinic AND extra pyramid
First gen other antipsychotic
Primozide, sulpride
Reduced sedation, antimuscarinic AND extra pyramidal
Antipsychotic monitoring weight
At start, weekly for first 6 weeks! At 12 weeks, 1 yr then annual
Antipsychotic blood glucose monitoring frequency
At start, as wks, 1 yr then annual